Entero Healthcare Solutions Intrinsic Value
ENTERO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹348.48 | ₹278.78 - ₹418.18 | -67.7% | EPS: ₹29.04, Sector P/E: 12x |
| Book Value Method | asset | ₹402.27 | ₹362.04 - ₹442.50 | -62.7% | Book Value/Share: ₹402.27, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1146.18 | ₹1031.56 - ₹1260.80 | +6.2% | Revenue/Share: ₹1432.73, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹431.68 | ₹388.51 - ₹474.85 | -60.0% | EBITDA: ₹268.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹323.76 | ₹291.38 - ₹356.14 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹323.76 | ₹291.38 - ₹356.14 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹539.60 | ₹485.64 - ₹593.56 | -50.0% | ROE: 8.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹512.68 | ₹461.41 - ₹563.95 | -52.5% | EPS: ₹29.04, BVPS: ₹402.27 |
Want to compare with current market value? Check ENTERO share price latest .
Valuation Comparison Chart
ENTERO Intrinsic Value Analysis
What is the intrinsic value of ENTERO?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Entero Healthcare Solutions (ENTERO) is ₹431.68 (median value). With the current market price of ₹1079.20, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹323.76 to ₹1146.18, indicating ₹323.76 - ₹1146.18.
Is ENTERO undervalued or overvalued?
Based on our multi-method analysis, Entero Healthcare Solutions (ENTERO) appears to be trading above calculated value by approximately 60.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 23.86 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.53 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 8.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.33x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Entero Healthcare Solutions
Additional stock information and data for ENTERO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-77 Cr | ₹-77 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-37 Cr | ₹-389 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-45 Cr | ₹-70 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-35 Cr | ₹-116 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-69 Cr | ₹-85 Cr | Negative Cash Flow | 3/10 |